Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

2.990

-0.180 (-5.68%)

At close: Nov 20, 2024, 4:00 PM

3.050

+0.060 (2.01%)

After-hours: Nov 20, 2024, 5:03 PM EST

Prime Medicine Employees

Prime Medicine had 234 employees as of December 31, 2023. The number of employees increased by 59 or 33.71% compared to the previous year.

Employees

234

Change (1Y)

59

Growth (1Y)

33.71%

Revenue / Employee

$3,419

Profits / Employee

-$936,962

Market Cap

381.51M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	234	59	33.71%
Dec 31, 2022	175	-	-

Related Stocks

Company Name	Employees
DocGo	4,164
Sonida Senior Living	3,955
Canopy Growth	1,029
Revance Therapeutics	597
Sangamo Therapeutics	405
Esperion Therapeutics	240
KalVista Pharmaceuticals	150
Rigel Pharmaceuticals	147

Employee Rankings

PRME News

4 hours ago - Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics - GlobeNewsWire
14 days ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
4 weeks ago - Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress - GlobeNewsWire
5 weeks ago - Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings - GlobeNewsWire
7 weeks ago - Crude Oil Moves Higher; Prime Medicine Shares Spike Higher - Benzinga
7 weeks ago - Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline - Benzinga
7 weeks ago - Prime Medicine Unveils Strategically Focused Pipeline - GlobeNewsWire
6 months ago - Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire